EMGE

Healthcare Drug Manufacturers - Specialty & Generic

Emergent Health Corp

$0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

42,695.11

Avg Volume

9,254

EPS

-$0.01

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.10

P/S Ratio

0.36

EV/EBITDA

-4.33

EV/Revenue

6.51

Margins

Gross Margin 66.5%

Operating Margin (289.9%)

Net Margin (241.5%)

EBITDA Margin (150.2%)

Growth & Returns

Return on Equity

(164.2%)

Return on Assets

(35.6%)

Liquidity & Leverage

Current Ratio

0.94

Quick Ratio

0.74

Total Cash

58,618

Total Debt

693,258

About

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.